chrisvoncsefalvay/vaers-outcomes huggingface dataset:
gangrenous appendicitis; vomiting; diarrhea; Abdominal pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 43 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 15Feb2021 (Lot number: EM9809) at the age of 43 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Appendicitis", start date: 20Sep2021 (unspecified if ongoing), notes: was admitted to ER and had appendectomy. Patient did not have allergies. Concomitant medication(s) included: TRI LO MARZIA. Vaccination history included: Bnt162b2 (lot number: EL3247, dose number: 1, vaccine location: Left arm), administration date: 25Jan2021, when the patient was 43 years old, for covid 19 immunization. The following information was reported: COMPLICATED APPENDICITIS (hospitalization, medically significant), outcome "unknown", described as "gangrenous appendicitis"; ABDOMINAL PAIN (hospitalization, medically significant) with onset 19Sep2021 10:00, outcome "unknown", described as "Abdominal pain"; CONDITION AGGRAVATED (hospitalization, medically significant) with onset 19Sep2021 01:30, outcome "unknown", described as "became worse"; Abdominal pain started around 10:00 Am on Sunday, 19Sep2021. Persisted through the day and became worse around 1:30 AM Monday, 20Sep2021. VOMITING (hospitalization, medically significant) with onset 20Sep2021, outcome "unknown", described as "vomiting"; DIARRHOEA (hospitalization, medically significant) with onset 20Sep2021, outcome "unknown", described as "diarrhea". The events "gangrenous appendicitis", "abdominal pain", "became worse", "vomiting" and "diarrhea" were evaluated at the emergency room visit. Vomiting and diarrhea began at that time as well. Around 9:00 AM patient went, after an examination, they sent to hospital where patient was then admitted. The patient underwent the following laboratory tests and procedures: blood test: (20Sep2021) 20-sep-2021, notes: unknown; computerised tomogram: (20Sep2021) confirmed appendicitis; sars-cov-2 test, Nasal Swab: (20Sep2021) negative. Patient did not have covid prior vaccination and tested for covid post vaccination. A CT scan and bloodwork was performed to confirm an appendicitis. The appendix had not yet ruptured but needed to be removed immediately. After the appendectomy, patient was told she had a gangrenous appendicitis. Since this surgery, she have heard of seven more acquaintances who had an appendectomy and the only common factor was that we all had the Pfizer vaccine.  Follow-up attempts are completed. No further information is expected.
Initial misuse report received from a healthcare professional on 23 January 2014 and at agency on 21 March 2014. This case was linked to other case linked to case 2014SA046378 being a same reporter. A patient unknown age and gender had received FLUZONE QIV subcutaneously. The patient received FLUZONE by incorrect route. No adverse event was reported. The list of documents held by sender: None.
Patient presented on 5/16 and informed pharmacist that she has been dealing with side effects of her booster dose that was administered in Feb.  The patient states that 2 days after getting her booster shot, she started having a lack of appetite, general tiredness, and diarrhea and vomiting.  She could not eat or drink much of anything without it experiencing the diarrhea or vomiting.  She went to urgent care, and they did blood tests, with the determination that it was a virus and there was not much else that could be done than to let it run its course.  The patient has lost approx. 30 pounds of weight since the vaccination, and is just now starting to recover from the side effects.  She has also had welts on her tongue, and has had some nerve issues with her tongue (feels like there is something on the end of her tongue, but nothing is on there)
(OMIC). Initial report received from a patients parent on Nov 7 2005. A 30 year old female patient with a medical history of asthma and an allergy to dog and cat dander received a left deltoid injection of Fluzone SV 2005-2006, lot number U1764AA, on Nov 4 2005. The route of administration was not reported. The patient had received no previous doses. Five to ten minutes following vaccination, the patient fainted. The patient was also shaking. She was examined in an emergency room and discharged. Per the reporter, an electrocardiogram was normal, and the patient had an elevated white blood cell count. There were no illness at the time of vaccination, although, the patient had an unspecified illness a week prior to vaccination. Other medications were birth control pills. At the time of this report, the recovery status was unknown.
Patient notes she had a normal retinal exam one year prior to recieving the vaccine. She notes a few weeks after getting the vaccine she started developing blurry vision. that was intermittent. I January she awoke to very blurry vison in her right eye and was found to prolific diabetic retinopathy and a retinal detachment.   Pateint is involved in the diabetic community and has heard reports from several of her freinds about worseing reitnopathy immediately following the covid vaccines.
left deltoid immediate blood sprayed from administration site and swelling in area, nodule 1x1 cm at injection site.  Narrative:  in person apt with occupational health NP 1/11 @11:25. left deltoid immediate blood sprayed from administration site and swelling in area, nodule 1x1 cm at injection site. NP advised to take ibuprofen 2 400 mg tablet.
We were told it was the dTAP, but unsure of the specific one or lot number etc. Pt started crying and screaming around 430 the evening she got her vaccinations. The second injection site was red and swelling. She was having trouble walking. We gave her motrin and it helped her sleep a little. She woke screaming several times through the night. We called the doc to report her symptoms. They told us to alternate tylenol/motrin to help with her pain/malase and to rub the injection site. She has had diarrhea since that day as well (noone else in the house does). This is the same way she reacted to the first dose of dTAP (extreme screaming and swelling of the injection site). All reactions were reported to the pediatrician.
red swelling at site of covid vaccine Covid vaccine given in lower portion of arm and flu vaccine given in upper portion of arm
The first injection was followed by minor discomfort at the injection site and arm. Following the second injection several symptoms occurred such as headache,muscle aches, exhaustion. Mild itching on my upper arms and torso began within the first 48 hours following this second injection. Within a short time a rash appeared.  As the days and weeks past itching worsened and it burned as the rash became much more pronounced. This discomfort persisted and made it quite difficult to get adequate sleep. I tried many remedies that would be commonly effective with a rash such as poison ivy but had no success. Seven months have passed and it is only the past two weeks that it seems to be lessening.
After about 6 hours of receiving the shot, I woke up with uncontrollable chills, and hot flashes in between, where my chest, back and face felt hot but hands and feet were ice cold. I had a fever of 99.9 and had a headache across the front of the face and nauesa. All of this lasted together for about 6 to 7 hours. During this time I took Tyenol, used cold compress, wrapped up in blankets and sipped on water. After the chills and hot flashes subsided I continued to feel fatigue,and had  head and body aches for the next 18-24 hours. During this time I continued with Tyenol and fluids. In all it last about 36 hours before I felt like myself again.
Redness and swelling on pt's right hand along with pain. Once pt noticed the symptoms, she called the pharmacy and was told to take some pain reliever, then if it does not get better to seek medical help. Symptoms started to get worse then she had to go to the ER where she was given some IV medications for pain and swelling. Per pt's after visit summary, she was given Benadryl, pepcid and methylprednison in the emergency room.
Pt did not mention that had BV before , after giving  realized that Pt had it before, no adverse reaction reported by the Pt
Headache, fatigue, muscle aching, chills, roaring in ears, nausea, sore red swollen at sight of injection. Started 12 hours after vaccination and lasted 12-14 hours.
Sore arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (Sore arm) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Fever: 105F going up and down; chills; sore throat; headache;  muscle weakness; pain at site of the shot; fatigue. I?m breastfeeding and my baby got fever too.
swelling on his ankle; felt a little achy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (felt a little achy) and JOINT SWELLING (swelling on his ankle) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included Rheumatoid arthritis.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN (felt a little achy). On an unknown date, the patient experienced JOINT SWELLING (swelling on his ankle). At the time of the report, PAIN (felt a little achy) and JOINT SWELLING (swelling on his ankle) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
This spontaneous report as received from nurse refers to two patients of unknown age. On an unknown date the patients were vaccinated with PNEUMOVAX 23 (lot # was not reported). The reporter reported PNEUMOVAX 23 was improperly stored. No adverse events were reported. This is one of the reports from the same reporter. Additional information has been requested.
I developed a keloid, which I thought it was going to be gone but it did not It was also very itchy for a while. I reported to my doctor and he prescribed steroids to lower the bump. It went down but still there it also itches occasionally after three years of the shot.
Next day after injection, large painful welt appeared. Remained for several days. One week later, welt reappeared, itched and started to grow larger in size
Vomiting, diarrhea, subjective fever 3d after vaccines/well child visit.
ADMINISTRATION OF EXPIRED VACCINE; This spontaneous report received from a health care professional concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 205A21A, and expiry: 21-SEP-2021) dose was not reported, administered on 29-SEP-2021 for prophylactic vaccination. No concomitant medications were reported.  On 29-SEP-2021, the patient experienced administration of expired vaccine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of administration of expired vaccine was not reported. This report was non-serious.
This spontaneous report as received from a pharmacist (pharmacy district manager) refers to a patient of unknown age. The patient's medical history was not reported. On an unknown date the patient was inadvertently vaccinated with a second dose of ZOSTAVAX. No symptoms reported. No product complaint was reported for ZOSTAVAX. Additional information has been requested.
Pain at the injection site. Shoulder pain and pain going down the arm.   Has difficulty moving arm.  Been taking tylenol and compresses.
Within 10 seconds, felt discomfort in right lower back.  quickly became more severe with spasms - not external muscles but internal.  Spasms become VERY rapid and severe with shooting staightline pain from right of spinal chord horizontally across back and spasming area.  Spasms and pain moved up back to waist, then moved to front, and continued up abdominal area stopping at rib cage.  At this point my husband was speeding to ED at Hospital since we had left outside clinic area.  Upon arrival, spasms and pain continued subsiding after about 45 minutes,  Had EKG, was monitored for vitals, had CT of abdomen.  Nothing unusual found except for cyst on ovary.  Did not receive any medications in ED.  Was discharged with no further events.  At follow-up, primary doctor recommended no more quadravalent.  Have had regular influenza shots annually for many years with no problems.
Wheezing started approx 4pm by 5pm wheezing worsened, rapid respirations. Mom gave Pulmicort, Xopenex neb. Sx Continued, was given Prednisolone 4ml oral. Treatment continued with Pulmicort and Xopenex through Sun 10/20/02.
She is in bed (reporting negative AE) as a result of the Moderna shot.; She is in bed (reporting negative AE) as a result of the Moderna shot.; This spontaneous case was reported by a patient and describes the occurrence of BEDRIDDEN (She is in bed (reporting negative AE) as a result of the Moderna shot.) and VACCINATION COMPLICATION (She is in bed (reporting negative AE) as a result of the Moderna shot.) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     Concurrent medical conditions included Lyme disease.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced BEDRIDDEN (She is in bed (reporting negative AE) as a result of the Moderna shot.) and VACCINATION COMPLICATION (She is in bed (reporting negative AE) as a result of the Moderna shot.). At the time of the report, BEDRIDDEN (She is in bed (reporting negative AE) as a result of the Moderna shot.) and VACCINATION COMPLICATION (She is in bed (reporting negative AE) as a result of the Moderna shot.) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.  No concomitant product use was reported.   No treatment information was provided.
Information has been received from a registered nurse referring to unspecified number of patients of unknown age and gender. On unknown dates the patients were vaccinated with GARDASIL (lot # K007264 with expiration date of 02-MAR-2017, dose, strength and route unknown), which were exposed to temperatures outside of the recommended range. No adverse effects had been reported. This is one of several reports received from the same reporter. Additional information has been requested.
ACUTE NON ST ELEVATION MI 5/21/2022 -- RECURRENCE OF SAME SYMPTOMS
Hard, Swollen, red, itchy patch of 2? diameter around the vaccination site.
Patient nearly passed out after receiving first dose. Patient's wife stated he was very nervous and did not eat since noon. He received his vaccination around 8:30pm that day. Fire department and EMS was called and the patient's vitals and EKG were normal. Patient did throw up while waiting post-vaccination. He was instructed to sit down but he was walking around the store.
pt recvd vax & devel hypotension, elevation in liver function tests, & mild disseminated intravascular coagulation; pt was adm to the hosp & recovered following tx;
Sinus infection; This spontaneous case was reported by a consumer and describes the occurrence of SINUSITIS (Sinus infection) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Rheumatoid arthritis.    No Medical History information was reported.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) at an unspecified dose. In 2021, the patient experienced SINUSITIS (Sinus infection). At the time of the report, SINUSITIS (Sinus infection) was resolving.            Concomitant medication was not provided.  Treatment medication information was not provided by the reporter.  It was unknown if patient was enrolled in a COVID-19 vaccine trial.  This case was identified as part of a retrospective clean-up activity where certain emails received in the moderna mailbox were missed to be booked-in.
Pt stated that 2nd vaccine was more than 6 months ago. Upon review of vaccine record it was revealed that 2nd does was actually 5 months ago. Pfzer was contacted. Per pharmacist with Pfizer, the dose does not need to be repeated and there is no information regarding potential side effects.
Vaccine given in Left deltoid. Below injection site red area size of baseball. Also swelling and painful.
Janssen COVID-19 Vaccine EUA Fever, Muscle Pain,fatigue, hand/arm and foot/leg pain
Broke out in rash that was raised starting with legs and arms and spread to back, torso and face. Broken blood vessels behind right knee
Pt was inadvertently injected with empty syringe/needle that contained no vaccine. Pt reported no pain at time of injection. Pt was advised of the error via telephone on 2/3/22 and pt was advised to receive vaccination, since none was received. Pt verbalized understanding; pt reports no pain or adverse effects at this time.
Given 24 hours after being drawn up.; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Given 24 hours after being drawn up.) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Given 24 hours after being drawn up.). On 14-May-2021, EXPIRED PRODUCT ADMINISTERED (Given 24 hours after being drawn up.) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Follow-up information received on 19-May-2021, contains non-significant information.
pt recv vax 22APR97 & the evening of 6MAY97 pt devel swelling of the lt parotid area & h/a & fever of 101;Md is not sure if pt actually recv MMR because pt vaccinated in Kenya;
my left bicep and shoulder cap are in pain two weeks after receiving vaccine. pain is most in the morning when i wake up. but is felt throughout the day any time i use the upper arm muscles. pain is similar to a muscle pain like from exercise.
This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). At the time of the report, OROPHARYNGEAL PAIN (sore throat) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No Concomitant medication were reported. No treatment information was reported. Reporter did not allow further contact.
Currently inpatient admission at (3) days.  Admit to medicine-severe COVID pneumonia, acute on chronic hypoxemic respiratory failure Symptom day #4, patient did receive Johnson & Johnson vaccine, initiate remdesivir they Daily renal and liver function monitoring for kidney and liver toxicity due to Remdesvir is required Patient is wheezy, received 125 mg Solu-Medrol in the emergency department Will continue Solu-Medrol 40 mg q.6 hours, scheduled albuterol inhaler Trend daily CRP, CMP, complete blood count, D-dimer, continuous pulse oximetry Encourage incentive spirometry and pronation, p.r.n. Tessalon Perles a 61 y.o. female with a history of severe oxygen dependent chronic obstructive pulmonary disease and chronic pain who presents today with shortness of breath, cough, nausea, and chest pain.  She says that her symptoms initially started but 4 days ago.  She has had chills, fevers, cough, nausea, and chest pain.  She notes that she is more short of breath than normal.  She has been using her home inhalers without much relief.  She has been vaccinated against COVID-19.  On arrival, she test positive for COVID-19.  She requires more oxygen than her baseline which is 2 L. she was tachycardic and tachypneic.  On exam, she is diaphoretic and tired.  She is wheezy but not using increased respiratory effort.  Plans are discussed for admission and she is agreeable.  She states that under no circumstances would she want have to live with the respirator, and as such she wants to be listed as DNR/DNI code status.
3-24-21 - Chills, body ache, stomach pain 3-25-21 - stomach pain continued, nausea 3-26-21 - intense stomach pain, throwing up, nausea, chest pain. Went to ER stomach pain was so extreme. Diagnosed with accurate pancreatitis admitted to hospital. During stay O2 level dropped to 73, extreme pain for multiple days.   21- The form won't let me fill in the hospital info 10 night stay in hospital.
Pt received Covid Vaccine at approximately 3:15 PM onsite d/t hx of anaphylatic reaction to IV vanc.  At 3:25 PM, pt report hives, itching, and tachycardia. Vital signs as follows: BP 90/66, HR 138,- irregular rhythm, Pulse ox 88% room air.  3:28 PM 0.5 mg epi IM and 100 mg Benadryl IM administered. Pt transported from lobby to exam room where o2 via NC at 2 LPM administered and crash cart present. EMS called.  3:30 Dr notified of reaction.  3:33 PM hives still present, sob reported. BP 170/88, HR 156, Pulse ox 99% w 2 LPM o2.  3:33 PM 2nd dose of 0.5 mg EPI administered IM.  3:35 BP 160/88, HR 98, o2 99% w 2 lpm o2. Hives, itching, sob resolved.  3:38 EMS arriving onsite for transport.  3:40  BP 140/88,  HR 86 o2 95 % on room air.  3:45 Pt transported to ambulance via wheelchair.